Cue Biopharma (CUE) Research & Development (2018 - 2025)
Historic Research & Development for Cue Biopharma (CUE) over the last 8 years, with Q3 2025 value amounting to $4.8 million.
- Cue Biopharma's Research & Development fell 4932.31% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.4 million, marking a year-over-year decrease of 2900.72%. This contributed to the annual value of $36.3 million for FY2024, which is 1104.6% down from last year.
- According to the latest figures from Q3 2025, Cue Biopharma's Research & Development is $4.8 million, which was down 4932.31% from $7.9 million recorded in Q2 2025.
- Cue Biopharma's 5-year Research & Development high stood at $11.5 million for Q4 2021, and its period low was $4.8 million during Q3 2025.
- In the last 5 years, Cue Biopharma's Research & Development had a median value of $9.6 million in 2022 and averaged $9.4 million.
- Per our database at Business Quant, Cue Biopharma's Research & Development surged by 5016.63% in 2021 and then tumbled by 4932.31% in 2025.
- Quarter analysis of 5 years shows Cue Biopharma's Research & Development stood at $11.5 million in 2021, then dropped by 1.47% to $11.3 million in 2022, then decreased by 3.93% to $10.9 million in 2023, then plummeted by 34.01% to $7.2 million in 2024, then plummeted by 33.83% to $4.8 million in 2025.
- Its Research & Development stands at $4.8 million for Q3 2025, versus $7.9 million for Q2 2025 and $8.5 million for Q1 2025.